Stefan Kaufmann

Director/Board Member at Bio Ventures for Global Health

76 year

Consumer Services

Health Technology

Stefan Kaufmann active positions

Companies	Position	Start	End
Vakzine Projekt Management GmbH Vakzine Projekt Management GmbH Pharmaceuticals: MajorHealth Technology Vakzine Projekt Management GmbH develops vaccines and biopharmaceuticals products from laboratory stages through to clinical examination. It offers VPM2001 vaccine to prevent human cytomegalovirus infections and VPM5001 Soluferon vaccine, treatment for multiple sclerosis (MS) and hepatitis C. The company was founded in August 2002 and is headquartered in Hannover, Germany.	Corporate Officer/Principal	-	-
Bio Ventures for Global Health	Director/Board Member	-	-

Companies	Position	Start	End
Universität Ulm	Corporate Officer/Principal	31/12/1997	31/12/1997

Max-Planck-Institute for Molecular Genetics	Undergraduate Degree
The Johannes Gutenberg University of Mainz	Doctorate Degree

International

Germany	5
United States	2

Operational

Corporate Officer/Principal	2
Undergraduate Degree	1
Doctorate Degree	1

Sectoral

Consumer Services	4
Health Technology	2

Positions held

Active

Inactive

Listed companies

Private companies

Private companies	2
Vakzine Projekt Management GmbH Vakzine Projekt Management GmbH Pharmaceuticals: MajorHealth Technology Vakzine Projekt Management GmbH develops vaccines and biopharmaceuticals products from laboratory stages through to clinical examination. It offers VPM2001 vaccine to prevent human cytomegalovirus infections and VPM5001 Soluferon vaccine, treatment for multiple sclerosis (MS) and hepatitis C. The company was founded in August 2002 and is headquartered in Hannover, Germany.	Health Technology
Bio Ventures for Global Health

Private companies

Health Technology

Bio Ventures for Global Health